BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19966541)

  • 1. Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.
    Gakhar G; Hua DH; Nguyen TA
    Anticancer Drugs; 2010 Jan; 21(1):77-88. PubMed ID: 19966541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the PQ1 anti-breast cancer agent on normal tissues.
    Ding Y; Prasain K; Nguyen TD; Hua DH; Nguyen TA
    Anticancer Drugs; 2012 Oct; 23(9):897-905. PubMed ID: 22569107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinational treatment of gap junction enhancers and paclitaxel attenuates mammary tumor growth.
    Shishido S; Nguyen TA
    Anticancer Drugs; 2020 Apr; 31(4):353-358. PubMed ID: 31913199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-breast cancer agents, quinolines, targeting gap junction.
    Bernzweig J; Heiniger B; Prasain K; Lu J; Hua DH; Nguyen TA
    Med Chem; 2011 Sep; 7(5):448-53. PubMed ID: 21801150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gap Junction Enhancer Potentiates Cytotoxicity of Cisplatin in Breast Cancer Cells.
    Ding Y; Nguyen TA
    J Cancer Sci Ther; 2012 Nov; 4(11):371-378. PubMed ID: 25045421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PQ1, a quinoline derivative, induces apoptosis in T47D breast cancer cells through activation of caspase-8 and caspase-9.
    Ding Y; Nguyen TA
    Apoptosis; 2013 Sep; 18(9):1071-82. PubMed ID: 23677255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivity and molecular targets of novel substituted quinolines in murine and human tumor cell lines in vitro.
    Perchellet EM; Crow KR; Gakhar G; Nguyen TA; Shi A; Hua DH; Perchellet JP
    Int J Oncol; 2010 Mar; 36(3):673-88. PubMed ID: 20126988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Apoptosis by PQ1, a Gap Junction Enhancer that Upregulates Connexin 43 and Activates the MAPK Signaling Pathway in Mammary Carcinoma Cells.
    Shishido SN; Nguyen TA
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
    Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gap junction enhancer increases efficacy of cisplatin to attenuate mammary tumor growth.
    Shishido SN; Nguyen TA
    PLoS One; 2012; 7(9):e44963. PubMed ID: 23028705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.
    Brüning A; Friese K; Burges A; Mylonas I
    Breast Cancer Res; 2010; 12(4):R45. PubMed ID: 20594311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
    Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
    BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apoptosis resistance induced by leptin and its mechanism in breast cancer cells].
    Zhao TS; Jiang HP; Wang XC; Ren H; Hao JH
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):651-4. PubMed ID: 20021858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of estrogen receptor-positive breast cancer cell lines to 4-hydroxytamoxifen by isothiocyanates present in cruciferous plants.
    Pawlik A; Słomińska-Wojewódzka M; Herman-Antosiewicz A
    Eur J Nutr; 2016 Apr; 55(3):1165-80. PubMed ID: 26014809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal combination of radiotherapy and endocrine drugs in breast cancer treatment.
    Zeng ZJ; Li JH; Zhang YJ; Zhao ST
    Cancer Radiother; 2013 Jun; 17(3):208-14. PubMed ID: 23664221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
    Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
    Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.
    Guo R; Huang Z; Shu Y; Jin S; Ge H
    Biomed Pharmacother; 2009 Jun; 63(5):375-9. PubMed ID: 18993026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quinoline derivative PQ1 combined with cisplatin promotes the proliferation and gap junction communication of prostate cancer PC3 cells].
    Lin YZ; Xu N; Li XD; Xue XY; Cai H; Wei Y; Zheng QS
    Zhonghua Nan Ke Xue; 2016 Feb; 22(2):116-21. PubMed ID: 26939394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
    Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
    J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.